Jul 10, 2026 07:28AM
Jul 6, 2026 07:01AM
Jul 3, 2026 01:31PM
Jul 2, 2026 01:24PM
Jun 23, 2026 07:49AM
Jun 11, 2026 01:21PM
Jun 6, 2026 07:02AM Insulet reports positive trial data for next-generation diabetes systems
Jun 3, 2026 07:02AM
May 27, 2026 09:26AM
May 26, 2026 04:28PM
May 26, 2026 04:06PM
May 20, 2026 08:35AM
May 12, 2026 05:47AM
May 8, 2026 08:00PM RBC sees over 80% upside to its price target for this medical stock
May 7, 2026 07:36AM
May 7, 2026 06:29AM
May 7, 2026 06:11AM
May 7, 2026 05:04AM
May 6, 2026 01:23PM
May 6, 2026 07:05AM
May 4, 2026 07:02AM Insulet begins pivotal trial for fully closed-loop diabetes system
Apr 24, 2026 03:13AM
Apr 18, 2026 10:00PM
Apr 7, 2026 06:38AM
Mar 12, 2026 04:05PM
Mar 11, 2026 04:01PM
Mar 9, 2026 08:18AM
Feb 19, 2026 07:55AM Insulet Corporation (PODD) PT Lowered to $330 at Bernstein
Feb 19, 2026 06:14AM
Feb 18, 2026 04:43PM
Feb 18, 2026 01:13PM
Feb 18, 2026 07:02AM
Feb 5, 2026 07:02AM
Jan 27, 2026 05:47AM
Jan 12, 2026 09:34AM Barclays Downgrades Insulet Corporation (PODD) to Underweight
Jan 12, 2026 09:34AM
Jan 9, 2026 07:33AM
Dec 18, 2025 09:45AM
Dec 16, 2025 06:01AM
Dec 15, 2025 07:42AM
Dec 15, 2025 07:00AM
Dec 4, 2025 09:35AM TD Cowen Reiterates Buy Rating on Insulet Corporation (PODD)
Nov 24, 2025 09:23AM
Nov 24, 2025 06:33AM
Nov 21, 2025 04:12PM
Nov 21, 2025 07:50AM
Nov 21, 2025 07:48AM
Nov 21, 2025 05:55AM
Nov 21, 2025 05:44AM Insulet Corporation (PODD) PT Raised to $412 at Truist Securities
Nov 21, 2025 05:38AM

417,303 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All